The recent cataloguing paper reported no ALK rearrangements and that 2% of pleural mesotheliomas had activating mutations in KRAS. However, the authors raised the possibility, given that their study had limited correlatory data that some cases may have been mis-diagnosed lung cancers and not mesothelioma [30•]. The gene discussed is KRAS; the disease is mesothelioma.